Image

    A Case Report of Biotin Treatment for Valproate-Induced Hair Loss

    Koen P. Grootens, Erwin G. Th. M. Hartong
    Studysummary In this letter, excessive hair loss due to telogen effluvium was observed as a distressing side effect in the early months of valproate treatment, potentially linked to disruption in biotin metabolism, although the exact mechanism remains unclear.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on psychiatrist.com →
    Discuss this study in the Community →

    Related research 7

    1. Bitemporal Scalp Hair Loss: Differential Diagnosis of Nonscarring and Scarring Conditions The Journal of clinical and aesthetic dermatology · 2021
    2. A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan Indian Journal of Dermatology · 2019
    3. A Case Report of Biotin Treatment for Valproate-Induced Hair Loss The Journal of Clinical Psychiatry · 2017
    4. Hair Loss in Children: Common and Uncommon Causes; Clinical and Epidemiological Study in Jordan International Journal of Trichology · 2013
    5. Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases Dermatologic Therapy · 2011
    6. Diagnosis of Hair Loss: Clinical Features of Common Causes PubMed · 1992
    7. Diagnosis and Management of the Hair Loss Patient PubMed · 1987